Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Payables (2016 - 2025)

Historic Payables for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $19.1 million.

  • Mesoblast's Payables rose 16990.1% to $19.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.1 million, marking a year-over-year increase of 16990.1%. This contributed to the annual value of $19.1 million for FY2025, which is 16990.1% up from last year.
  • According to the latest figures from Q2 2025, Mesoblast's Payables is $19.1 million, which was up 16990.1% from $11.9 million recorded in Q4 2024.
  • In the past 5 years, Mesoblast's Payables ranged from a high of $24.3 million in Q1 2021 and a low of $7.1 million during Q2 2024
  • Its 5-year average for Payables is $18.1 million, with a median of $19.3 million in 2021.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 6490.44% in 2024, then soared by 16990.1% in 2025.
  • Over the past 5 years, Mesoblast's Payables (Quarter) stood at $20.9 million in 2021, then increased by 9.91% to $23.0 million in 2022, then plummeted by 53.2% to $10.8 million in 2023, then grew by 10.22% to $11.9 million in 2024, then surged by 60.89% to $19.1 million in 2025.
  • Its Payables stands at $19.1 million for Q2 2025, versus $11.9 million for Q4 2024 and $7.1 million for Q2 2024.